Get started
Vaxart, Inc. - Common StockVaxart, Inc. - Common StockVaxart, Inc. - Common Stock

Vaxart, Inc. - Common Stock

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

VXRT trade ideas

VXRT Vol + Fibs = ?VXRT testing another familiar area of "traffic" from the last few months. This 786 fib area has remained a key level on the chart. More times than not, VXRT has failed to break and hold above it for any meaningful amount of time. But thanks to new covid cases and its recent business update, things are popping on Aug 9th. Though the volume isn't anything crazy above average, the last few days of consistently higher levels are something to watch closely as well. " Another one of the former penny stocks to watch on this list is Vaxart Inc. While short interest isn’t the only focus right now, for VXRT, it has played a role. Based on the most recent data, the short float percentage is right around 20%. What’s more, the company’s recent business update helped shed a brighter light on a few things that were up in the air during more recent weeks...One of the topics discussed was the potential of Vaxart’s R&D and clinical development initiatives. CEO Andrei Floroiu said, “We strengthened our balance sheet, made major research advances, deepened our scientific knowledge, grew the company, and took the company closer to our goal of developing disruptive oral tablet vaccines that can have a material impact on the world’s public health.” ...Vaxart’s platform has shown progress in recent clinical trials. Its norovirus vaccine, built on the company’s VAAST platform, demonstrated the ability to boost immune responses in those who’ve been previously vaccinated with a Vaxart oral vaccine. In some cases, this vaccination period was more than a year earlier. The company also has a current trial study going on. This is of its S-Wuhan construct, which it expects to begin shortly. Obviously, with growing virus cases and the eventual rise of “cold and flu season,” this early progress has begun to gain attention in the market. " Quote Source & Read More: 4 Penny Stocks On Robinhood To Watch This Week
NASDAQ:VXRT
by PennyStocks101
$VXRT Target 13.62 for 51% $VXRT Target 13.62 for 51% Or next add at 7.87 (5day low) No add here... same position and target. Might see a little resistance here to push through... ----- — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. ONLY ADD at support levels & FIB levels… labeled I start every position with .5 - 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading.
NASDAQ:VXRTLong
by SPYder_QQQueen_Trading
2
VXRT bullish bullish momentumChart posted approx 10:42 am ET. I have been in this one since the last pump to 9.15.. and it immediately sold off. Holding because there are some significant signs of a BIG swing back up. Given the recent variant and delta cases going up helps support this. However what tells me there may be some upside potential is the Harmonics. VXRT doesn't seem to be giving up the ghost. We are consolidating on what appears to be extreme bull support of a 786 on the crab pattern (blue)- ranging as well. Keep in mind we have already moved back up on the bearish shark (yellow) without failing- this is added energy to go upside. Both of these are fueld off a bullish crab pattern as well. This is hella bullish for me. This is yet another embedded harmonic pattern - the macro pattern is bearish butterfly. You see these when the markets are unsure of themselves. VXRT is gaining some ground today. When this moves it will move quickly. Target here 12.23-12.50 on low side, and 16.40 extreme side. Lets go SET STOPS if you need em.
NASDAQ:VXRTLong
by Moorsc0de
2
$VXRT entry Target PTs 7.20-8-8.20 Long term PTs 75-200-500$VXRT entry Target PTs 7.20-8-8.20 Long term PTs 75-200-500 and higher...timeline Sept 2022 Wyckoff Re-accumulation after decline Catalyst: Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral Coronavirus vaccine. Why Vaxart Stock Surged Today The vaccine maker has a promising new construct for its experimental COVID-19 tablet. What happened Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart's stock price was up more than 12%. So what Vaxart's S-only vaccine construct produced higher serum antibodies than its other vaccine candidate, which expresses both S and N proteins, in a non-human primate study. Vaxart plans to begin a phase II clinical trial for its S-only vaccine later this year. "This new clinical trial will allow us to compare the S-only and S+N vaccine candidates and put us in a position to decide which approach offers the best way forward for our COVID-19 vaccine development program, particularly in the face of emerging variant strains," Vaxart's chief scientific officer Dr. Sean Tucker said in a press release. Now what If Vaxart's new vaccine construct can produce a stronger antibody response in human patients than its other oral vaccine did in prior studies, it could become a more legitimate competitor to the COVID-19 drugs developed by Pfizer and Moderna. As a tablet, Vaxart's oral vaccine would be easier to store, transfer, and administer. If Vaxart can demonstrate a comparable efficacy and safety profile to the leading vaccines currently on the market, there would likely be tremendous demand for its new drug. This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.
NASDAQ:VXRTLong
by BADQOMOCAWGOWLD
2
VXRT Vaxart Covid-19, Uptrend and Price TargetVXA-CoV2-1, Vaxart's experimental treatment for Covid-19 is unique in that it's a pill, not an injection. A pill would certainly be easier from a distribution and administration standpoint but also to get higher vaccination rates. On May 3, Vaxart's treatment showed demonstrable CD8 T-cell responses, but didn't produce high levels of neutralizing antibodies in trial participants, which makes it less efficient than traditional COVID-19 injections. On 6/11/2021 Piper Sandler brokerage Initiated Coverage with Overweight rating and a Price Target of $18.00 From a technical analysis point of view, the stock looks in an uptrend.
NASDAQ:VXRTLong
by TopgOptions
$VXRT Target 13.62 for 48.04%$VXRT Target 13.62 for 48.04% Or double position at 4.78 This one is finding support here too... I like trading this one too... haha. One of my favorite Biotech stocks for sure. — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading. I finally added my YouTube Training Video to my profile tagline since I’m not allowed to on here. It’s a quick 15 minute training video on how to set up your chart and how to spot opportunities. So check here first but If you have questions just message me.
NASDAQ:VXRTLong
by SPYder_QQQueen_Trading
6
VXRT - Time to sink 🐻-There certainly appears to be a market for oral vaccines. However, it may be years before the company delivers a product to meet that opportunity. -VXRT stock has been dropping significantly after the company released data on its Phase 1 study. The results weren’t bad, but not what analysts were expecting. Vaxart CEO Andrei Floroiu stated, “Our vaccine’s immune response appears very different than that seen from the leading injectables…” -Time will tell if that is a better approach. But time is not on Vaxart’s side at least as it relates to Covid-19. With each passing day, more Americans become fully vaccinated. And in one of its latest announcements this week, the Center for Disease Control (CDC) said that data suggests individuals who have recovered from even a mild case of Covid-19 may have long-lasting antibody production. This would reduce, or altogether eliminate, the need for those individuals to be vaccinated. -The good news is the company has several other vaccine candidates in their pipeline. However, none of those candidates are further along than its Covid-19 candidate. -It should be obvious that any investor looking to take a position in VXRT stock should keep their position small. Vaxart does not yet have a product that’s in market and it could be several years before they do.
NASDAQ:VXRTShort
by caldooninvestment
27
$VXRT Target 13.83 for 46.97% $VXRT Target 13.83 for 46.97% Or next add level is at 4.99 No commentary here... just let's go... haha. 😂 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading.
NASDAQ:VXRTLong
by SPYder_QQQueen_Trading
2